Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pyxis Oncology (PYXS) FCF Margin (2024 - 2025)

Pyxis Oncology (PYXS) has disclosed FCF Margin for 2 consecutive years, with 94.46% as the latest value for Q4 2025.

  • Quarterly FCF Margin changed N/A to 94.46% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 458.23% through Dec 2025, down 9958.0% year-over-year, with the annual reading at 458.3% for FY2025, 9964.0% down from the prior year.
  • FCF Margin for Q4 2025 was 94.46% at Pyxis Oncology, up from 612.16% in the prior quarter.
  • The five-year high for FCF Margin was 94.46% in Q4 2025, with the low at 612.16% in Q2 2025.